Breast Cancer Group,Genito-Urinary Cancers Group,Lymphoma Group,News,Radiation Oncology Group,Uncategorized
Studies opened since 1 January 2010
12 Mar 2010
EORTC trial 22085-10083
TROG 07.01
A randomised phase III study of radiation doses and fractionation schedules for ductal carcinoma in situ (DCIS) of the breast
STUDIES IN REGULATORY PROCESS
EORTC trial 10085
Clinical and biological characterization of Male Breast Cancer: an international retrospective EORTC, BIG and NABCG intergroup study
EORTC trial 21081
A phase III study of lenalidomide maintenance after debulking with gemcitabine or liposomal doxorubicin +/- radiotherapy in patients with advanced cutaneous T-cell lymphoma not previously treated with intravenous chemotherapy
EORTC trial 30073
Randomized phase III trial comparing immediate versus deferred nephrectomy in patients with synchronous metastatic renal cell carcinoma.
SURTIME SURgery TIME
Related News
EORTC-1333-GUCG/PEACE III trial endpoint reached
12 Jul 2024
Meet the new EORTC Board
9 Jul 2024
EORTC-1333-GUCG/PEACE III Trial Statement
28 Jun 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024